Table 2.
Respiratory—nasal and bronchial | |||
---|---|---|---|
Airway explant spheroid | Airway basal cell spheroid | Long term expanding airway organoid | |
Method 1—Dome Method 2–25% layer | |||
Cultures | |||
Cellular source | Freshly isolated non-dissociated airway epithelial sheets | Airway basal progenitor cells expanded as traditional primary cultures or conditionally reprogrammed cultures | Lung biopsies and cells from BAL fluid |
Media | Standard, non-differentiating culture media e.g., BEGM | Differentiation media—same as those used for 2D ALI cultures | Media containing biochemical cues for self-renewal. Content: Advanced DMEM/F12 R-Spondin 1 Noggin FGF 7 FGF 10 A83-01 Y-27632 SB202190 B27 supplement N-Acetylcysteine Nicotinamide Glutamax |
Require ECM (matrigel) | No | Yes | Yes |
Constitute differentiated epithelium structure | Yes (ex vivo—already differentiated) | Yes (after 14–21 days culture) | Yes (duration to form not reported) |
Orientation of apical ciliated side | Facing outwards (media) | Facing inwards (lumen) | Facing inwards (lumen) |
Use of cultures | End-point experiments | End-point experiments | Can be passaged for on-going cultures (reported up to P18) |
CFTR functional assay | Yes—spheroids shrink when CFTR is activated | Yes—spheroids swell when CFTR is activated | Yes—spheroids swell when CFTR is activated |
Cryopreservation | No | No | Not reported |
References | Bridges et al., 1991 Pedersen et al., 1999 Deslee et al., 2007 Guimbellot et al., 2017 | Danahay et al., 2015 Hild and Jaffe, 2016 Brewington et al., 2018c | Sachs et al., 2018 Zhou et al., 2018 |
2D, Two-dimensional; ALI, Air-liquid interphase; BAL, Bronchoalveolar lavage; BEGM, Bronchial epithelial cell growth media; ECM, Extracellular matrix; FGF, Fibroblast growth factor; TGF-β, Transforming growth factor-beta.